China Nonprescription Medicines Association Releases 2008 OTC Sales Ranking List
This article was originally published in PharmAsia News
Executive SummaryAt the recent China Self-Medication Annual Meeting, China's Nonprescription Medicines Association released its annual statistics and survey results of the local OTC businesses. Xiuzheng Pharmaceutical Group, Xian-Janssen, Harbin Pharmaceutical Group, Sanjiu Medical & Pharmaceutical and TSKF are listed as the five companies with biggest sales in 2008. For OTC chemical drugs, TSKF's Fenbid, Bayer's Saridon, Shanghai Johnson & Johnson's Motrin and Tylenol, and HPG's Anruike garnered the top spots. TSKF's new Contac and Bayer's White & Black were among the top five for cold and cough; Wyeth's Caltrate D and Bayer'sRedoxon for vitamins and minerals; Xian-Janssen's Motilium and Bayer's Talcid for digestives; and Xian-Janssen's Daktarin and Pevisone for external use agents. Local products dominated in patent TCM, surgery and women's health sectors. (Click here for more - Chinese language)
You may also be interested in...
Lannett’s Phase I trial for biosimilar insulin glargine has met “all primary endpoints,” the company has announced. The rival to Sanofi’s Lantus is being developed by Lannett with partner HEC through a deal for which financial details have just been revealed.
Sanofi Consumer Healthcare is to operate as a standalone unit in a move which is being viewed as a prelude to a potential spin-off. High profile prescription-to-OTC switches are a priority for the revamped business.
Data integrity issues were raised in many warning letters to active pharmaceutical ingredient manufacturers over the past four years.